Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECTRIMS 2021 | Characterizing the autoantigen-specific T-cell repertoire in MS

Olivia Thomas, PhD, Karolinska Institute, Solna, Sweden, discusses her latest work on developing a method to characterize the autoreactive T-cell repertoire in vitro in patients with multiple sclerosis (MS). The study used a bead-coupling method to test T-cell autoreactivity in patients receiving natalizumab treatment, first to myelin oligodendrocyte glycoprotein (MOG), and then to 63 other candidate autoantigens. Strong autoreactivity was identified to 4 of these antigens. Dr Thomas discusses these findings, highlighting differences found between healthy patients and those with MS. The possibility of using this bead-coupling method in the future, as a diagnostic device to predict disease not just for MS, but for other autoreactive diseases, is also discussed. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress 2021.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.